Most brands read a banned-ingredient notice as a legal footnote until the day a market authority publishes a change that touches a formula already in production. The cost of that habit is not the change itself but the gap between the publication date & the moment someone in the brand actually reads it. A restriction that lands three months before a renewal, or two weeks before a production slot, is a scheduling problem with a hard date attached, & the factory cannot move the date for you.
This article sets out how restricted lists actually change, how a change travels from a regulator's page to a finished batch, how to screen a formula you already sell, & what to put in a brief so that the next update becomes a routine check rather than a scramble. It is written for the brand owner or procurement lead who holds the formula file, not for the regulatory consultant who will do the formal assessment later.
Why a banned-list change is a production event, not a legal footnote
A restriction is published on a date the authority chooses, not on a date that suits your launch. By the time the brand's regulatory contact sees it, the clock may already be running on a transition period, & the factory that holds your batch slot has its own queue. The change is therefore a production event the moment it is visible, because it can block a batch, a notification, or a shipment that was already planned.
The practical consequence is that the person who reads the notice should be inside the brand, not outside it. A brand that waits for its manufacturer to flag a restriction has handed the timing to a supplier that may serve hundreds of formulas & may not know which markets each one targets. The brand holds that market knowledge, so the brand should hold the monitoring too, or pay for a service that reports into the brand directly.
What makes the event costly is the lag. A formula screened today is cheap to adjust; the same formula screened after the artwork is printed, the batch is booked, & the freight is quoted is a relaunch. The difference between those two outcomes is often a single quarterly review that nobody owned.
The lists that actually move, & where restrictions are published
Restrictions live in more than one place, & a brand that watches only one will miss the others. The primary source is the market's positive or negative list maintained by the authority: the annex that names prohibited substances, the list that sets concentration limits for restricted ones, & the inventory of colorants, preservatives, & UV filters that are permitted at all. Each of these is updated on its own cadence.
A second source is the fragrance standard body, whose limits on specific molecules move on a different clock & reach the brand through the fragrance house rather than the authority. A third is the transport regulator, whose hazard class for a substance can change even when the cosmetic rule does not. A brand sourcing from Asia for Europe, the Gulf, & North America should expect three or four distinct feeds, not one.
The discipline that pays is to name the feeds, assign an owner, & record the last-checked date for each. The INCI naming convention is what makes the comparison possible, because a restriction is written against an INCI name, & a formula keyed to INCI names can be screened by a simple match rather than a chemist's reading. More on the naming step is in our note on INCI names.
What "restricted" means versus "banned" in practice
"Banned" is the simpler case: the substance may not appear in the product at any level in that market. "Restricted" is the harder one, because it sets a maximum concentration, a field of application, or a label warning, & each of those limits changes how the formula is built & how the pack is printed. A brand that reads "restricted" as "allowed" has missed the condition that attaches to the permission.
The concentration limit is where most errors sit. A preservative permitted at a certain level in a rinse-off product may be capped lower in a leave-on, or barred from a product meant for children. The same molecule can be lawful in one format & unlawful in another, so the screen has to run against the format, not just the substance. A single formula sold as both a wash & a cream needs two screens.
The label warning is the second condition. A restricted substance above a threshold may force an allergen declaration, a caution statement, or a prohibited claim. Those outputs are part of the restriction, not an extra, & they have to reach the artwork before the batch is filled. The brand that reads the limit as the only task forgets the label that the limit triggers.
How a change reaches your formula: the path from notice to batch
A restriction does not jump from a website to your bulk tank. It moves through a chain: the authority publishes, the responsible person notes it, the formula is screened, the affected markets are listed, the label is updated, the specification is revised, & only then does the next batch reflect it. At each step someone has to act, & at each step a delay pushes the cost forward.
The weak link is usually the handoff between reading & screening. A notice filed in a folder is not a formula change; the change happens when the screen runs & the result is recorded against the formula version. A brand that files notices but never re-screens the formulas is compliant on paper & exposed in the warehouse, because the product it ships still carries the old composition.
The factory's role starts at the batch. A good manufacturer will not fill a formula it knows is now restricted in the destination, but it will only know if the brand told it the destination & the current limit. The screen is the brand's job; the batch rejection is the factory's safety net, & the two only work when the brand feeds the factory the result of its own check.
Screening an existing formula against a new restriction
Screening is a match, not an analysis. Take the restricted INCI name, search the formula & the specification for it, note the concentration, & compare that concentration to the new limit for the format & the market. Where the substance is absent, the formula passes with a recorded line. Where it is present under the limit, the formula passes with a note. Where it is over, the formula fails & the action is triggered.
The trap is the hidden source. A restricted molecule may enter not as a listed active but as part of a fragrance, a plant extract, or a preservative blend, where it is declared under a different name or inside a composite. The screen has to run on the full component list, including the fragrance sub-components the brand rarely sees, or it will report a pass that the authority would not. This is why the fragrance declaration matters as much as the formula itself.
The output of a screen should be a dated record per formula per market, not a feeling. A brand that can show, for each product, when it last screened & what the result was, has turned a vague worry into a defensible position. The record is what a market authority or a retailer will ask for, & it is far easier to keep than to reconstruct after a question lands.
Reformulation when an ingredient is restricted: scope & limits
When a screen fails, the brand faces a choice: remove the substance, lower it under the limit, or withdraw the product from that market. Each choice has a cost, & the choice should be made on the brief rather than discovered during production. A removal can change the product's character, a reduction can change its performance, & a withdrawal loses the shelf space.
The part that is easy to overstate is the claim. A restricted substance is often the one a brand wanted to talk about, & the rule is strict here: the brand may not present a restricted or prohibited function as a selling point, & it must not phrase a compliance fix as a benefit. The work is to bring the formula inside the line, state only what the law allows, & drop the wording that the restriction took off the table. The route from a failed screen to a lawful formula is set out in our reformulation guide.
The limits on what can be promised are not a suggestion. Where the restriction touches a function that reads like a medical claim, the brand should step back further & confirm the wording stays within cosmetic scope. An article that explains the boundary between a cosmetic claim & a medical one is the safer read before the label is written, because the restriction is only one of several lines the copy must not cross.
Labelling, the product information file, & what must stay in sync
A restriction changes more than the bulk. It can change the ingredient list, the warning statement, the batch record, & the product information file that sits behind the notification. All of those have to move together, or the product on the shelf will contradict the file the authority holds, which is the finding a brand least wants at an inspection.
The ingredient list is the first to shift when an INCI name is added or removed. The warning is the second, where a threshold pushes a declaration onto the pack. The product information file is the third, because it records the basis for the formula & the safety assessment, & a restricted substance that changed the formula should also change the assessment note. A brand that updates one of these but not the others has a file that does not match its own product.
The practical control is a single change note that lists every artefact the restriction touches, with an owner for each. The note turns a vague "we updated the label" into a closed loop: list changed, warning changed, file changed, batch record changed, notification updated. Without that note the items drift apart, & the drift is exactly what an auditor finds first.
The records that prove you tracked the change
The record set that shows a brand tracked a restriction is smaller than a full dossier but stricter than a memory. It should hold the dated screen result per formula per market, the version of the specification that was in force when the screen ran, the change note that listed the artefacts updated, & the notification reference after the update was filed. Each item should carry a date & a name.
The certificate of analysis & the batch record support the same story from the factory side. The certificate shows what was in the lot; the batch record shows the version of the formula that produced it; the retention sample lets the brand go back to a specific batch if a question arises years later. Together they answer the only question that matters in a dispute: did this batch comply with the rule that applied on the day it was made.
For a buyer the test is whether the set can be produced within a working day, in writing, without reconstructing history. A brand that can do that has turned compliance from a panic into a process. The records are the proof that the tracking was real, not a story told after the fact when a market wrote to ask why a restricted substance was still on a pack.
IFRA & fragrance allergens inside the restricted-list picture
Fragrance sits inside the restricted-list picture in a way solid actives do not, because a scent is a blend of many molecules, some of which sit on a limit. The fragrance standard body sets those limits, & the fragrance house passes them to the brand as an allergen declaration & a compliance certificate. A brand that reads the fragrance as a single item misses the components the restriction actually watches.
The practical step is to hold the allergen declaration for each fragrance lot & to screen it against the destination limits before the batch is filled. Where a restricted molecule appears above the threshold, the label may need an allergen statement, & the formula may need a different fragrance version. The declaration is not paperwork to file; it is the screen input for the scent, & it should be read with the same care as the formula screen.
The point to hold is that a fragrance change made to satisfy a restriction is a formula change like any other, & it should move through the same note, the same file update, & the same batch record. A brand that updates the scent quietly, without touching the records, has a pack that complies & a file that does not, which is the gap an inspection is built to find.
Transport class, flash point, & hazard when restricted substances shift
A restriction can also move a substance from one hazard class to another, & that change reaches the brand through the safety data sheet rather than the cosmetic rule. A solvent or an alcohol that was routine can become a classified liquid, which changes how the bulk is stored, labelled, & moved. The flash point is the number that decides much of this, & it belongs in the brief for any formula built on volatile materials.
The transport effect is easy to overlook because it sits with the freight forwarder, not the formulation lab. A product that was cheap to air-freight can become a dangerous goods shipment the day a component crosses a threshold, & the cost & the lead time both rise. A brand that learns this at the booking desk has already missed the window to choose a substitute that would have kept the old class.
The control is to ask the factory for the safety data sheet per formula, not per grade, & to re-request it when a restriction changes a component. The sheet is what the forwarder reads to class the goods, & a brand that holds the current sheet can plan the freight before the restriction bites. The hazard class is part of the restricted-list picture even when the cosmetic authority never mentions it.
How often each list type changes, & what to watch
The table below sets the main list types against who maintains them, how often they tend to move, & what a brand should do with each. It is a comparison to plan a routine around, not a set of fixed dates, because every authority publishes on its own schedule & a brand should confirm the current position for each market rather than trust a pattern.
| List type | Who maintains it | How often it changes | What a brand must do |
|---|---|---|---|
| Prohibited substance annex | The market authority | Several times a year | Screen every formula before each notification |
| Restricted concentration limits | The market authority | Periodic | Confirm margin for format & market |
| Permitted preservatives | The market authority | Periodic | Verify the preservative choice holds |
| Permitted colorants | The market authority | Occasional | Audit pigments & heavy metal limits |
| UV filter list | The market authority | Periodic | Check filter & claimed level |
| IFRA standards | The fragrance body | Every few years plus updates | Re-screen each fragrance compound |
| Nano material inventory | The market authority | Periodic | Declare nano where used |
| Allergen labelling thresholds | The market authority | Periodic | Update label declarations |
The rows are a comparison, not fixed values, & the order in which a brand checks them should follow the risk: a substance on the prohibited annex beats a nano inventory in urgency. A routine that touches the high-movement lists every quarter & the slower ones every six months will catch most changes before they reach a batch, which is the whole point of tracking.
A tracking routine a small brand can actually keep
A small brand does not need a department; it needs a calendar. Pick the markets, list the formulas, name the feeds, & assign one owner to run the screen each quarter & to record the result. The work is an hour per formula per round, not a project, & the record it produces is what turns a future emergency into a line item the brand already planned for.
The routine should also cover the trigger: when a screen fails, what happens next. The brief should name the person who decides remove, reduce, or withdraw, the person who updates the label, & the person who files the notification. A routine without a trigger is a report nobody acts on, & the restriction will still reach the batch through the gap between reading & doing.
The cheapest version of the routine is a spreadsheet with one row per formula per market, a last-checked date, & a result column. It is not elegant, but it is defensible, & a defensible record is worth more than an elegant system that nobody opens. The brand that keeps the sheet owns its own compliance, & the factory becomes the safety net rather than the source of truth.
What to put in the brief
Brief the restricted-list screen as a standing task, not a one-off, & tie it to the markets you sell into so the factory knows which limits apply to the batch it is about to fill. Name the owner inside the brand, set the cadence, & agree what a failed screen triggers before the restriction ever appears, so the response is a plan rather than a panic.
- The markets you sell into, & any you plan to add within two years.
- The current formula version, & the specification sheet that releases it.
- The critical materials most likely to be restricted: preservatives, UV filters, fragrance molecules, colorants.
- The banned-list sources you monitor, & how often each is checked.
- The action a restriction triggers: screen, reformulate, or relabel.
- The label & notification owner, & the lead time each change needs.
- The records that prove the screen was done, & where they are kept.
- The review date, & the named person who runs it.
Then keep the screen next to the formula, & re-run it whenever a market publishes a change or a new market is added. A restriction read nine months early is a scheduling note; the same restriction read in the month of shipment is a crisis, & the brief is what decides which of the two the brand gets.
Where our capability fits
We keep a current formula version, a specification sheet, & a record of the restricted-list checks we run for every order we produce, & we screen a formula against the destinations you name before we batch it rather than after a question arrives. Where a material sits on a restricted list in one market but not another, we say so at the brief stage so the label & the batch record match the destination.
We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing & full custom formula development, & the compliance screen is set at the start of the project rather than at the end. Our lines include a custom formula face serum, a fragrance facial cleanser, shampoo & body wash range & custom softgel face serum capsules, all produced with the same restricted-list discipline a cross-market launch needs.
Tell us the markets you sell into & the formula you plan to launch, & we will come back with the restrictions that touch it & the screening each destination requires. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319.
General manufacturing information, not regulatory or legal advice. Banned & restricted lists, labelling duties & notification requirements vary by market, & the applicable position should be confirmed for each destination before a product is placed on sale.